Logo image of ALAGP.PA

AGRIPOWER FRANCE SA (ALAGP.PA) Stock Fundamental Analysis

EPA:ALAGP - Euronext Paris - Matif - FR0013452281 - Common Stock - Currency: EUR

1.12  +0.02 (+1.82%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALAGP. ALAGP was compared to 109 industry peers in the Machinery industry. While ALAGP seems to be doing ok healthwise, there are quite some concerns on its profitability. ALAGP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALAGP had negative earnings in the past year.
ALAGP had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALAGP reported negative net income in multiple years.
In the past 5 years ALAGP always reported negative operating cash flow.
ALAGP.PA Yearly Net Income VS EBIT VS OCF VS FCFALAGP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

ALAGP has a Return On Assets of -36.44%. This is amonst the worse of the industry: ALAGP underperforms 88.07% of its industry peers.
With a Return On Equity value of -68.85%, ALAGP is not doing good in the industry: 85.32% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -36.44%
ROE -68.85%
ROIC N/A
ROA(3y)-15.07%
ROA(5y)-8.88%
ROE(3y)-28.44%
ROE(5y)-16.79%
ROIC(3y)N/A
ROIC(5y)N/A
ALAGP.PA Yearly ROA, ROE, ROICALAGP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

ALAGP's Gross Margin of 21.83% is on the low side compared to the rest of the industry. ALAGP is outperformed by 79.82% of its industry peers.
ALAGP's Gross Margin has declined in the last couple of years.
ALAGP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.88%
GM growth 5Y-25.72%
ALAGP.PA Yearly Profit, Operating, Gross MarginsALAGP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

4

2. Health

2.1 Basic Checks

ALAGP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALAGP has been increased compared to 1 year ago.
The number of shares outstanding for ALAGP has been increased compared to 5 years ago.
ALAGP has a worse debt/assets ratio than last year.
ALAGP.PA Yearly Shares OutstandingALAGP.PA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALAGP.PA Yearly Total Debt VS Total AssetsALAGP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -0.80, we must say that ALAGP is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALAGP (-0.80) is worse than 75.23% of its industry peers.
ALAGP has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALAGP (0.30) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z -0.8
ROIC/WACCN/A
WACC8.27%
ALAGP.PA Yearly LT Debt VS Equity VS FCFALAGP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

ALAGP has a Current Ratio of 3.74. This indicates that ALAGP is financially healthy and has no problem in meeting its short term obligations.
ALAGP has a Current ratio of 3.74. This is amongst the best in the industry. ALAGP outperforms 92.66% of its industry peers.
ALAGP has a Quick Ratio of 3.52. This indicates that ALAGP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.52, ALAGP belongs to the top of the industry, outperforming 94.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.74
Quick Ratio 3.52
ALAGP.PA Yearly Current Assets VS Current LiabilitesALAGP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ALAGP have decreased strongly by -117.70% in the last year.
The Revenue for ALAGP has decreased by -76.93% in the past year. This is quite bad
Measured over the past years, ALAGP shows a very negative growth in Revenue. The Revenue has been decreasing by -28.23% on average per year.
EPS 1Y (TTM)-117.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.94%
Revenue 1Y (TTM)-76.93%
Revenue growth 3Y-45.36%
Revenue growth 5Y-28.23%
Sales Q2Q%-68.25%

3.2 Future

ALAGP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 106.83% yearly.
Based on estimates for the next years, ALAGP will show a very strong growth in Revenue. The Revenue will grow by 36.73% on average per year.
EPS Next Y166.67%
EPS Next 2Y106.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.83%
Revenue Next 2Y36.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALAGP.PA Yearly Revenue VS EstimatesALAGP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B 10B
ALAGP.PA Yearly EPS VS EstimatesALAGP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALAGP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 9.06, the valuation of ALAGP can be described as very reasonable.
Based on the Price/Forward Earnings ratio, ALAGP is valued a bit cheaper than the industry average as 77.98% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ALAGP to the average of the S&P500 Index (22.06), we can say ALAGP is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.06
ALAGP.PA Price Earnings VS Forward Price EarningsALAGP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALAGP.PA Per share dataALAGP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

ALAGP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALAGP's earnings are expected to grow with 106.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y106.83%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALAGP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGRIPOWER FRANCE SA

EPA:ALAGP (6/5/2025, 7:00:00 PM)

1.12

+0.02 (+1.82%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-27 2025-03-27
Earnings (Next)10-08 2025-10-08
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.39%
Ins Owner ChangeN/A
Market Cap4.03M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.06
P/S 2.93
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.6
EV/EBITDA N/A
EPS(TTM)-1.37
EYN/A
EPS(NY)0.12
Fwd EY11.04%
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.38
BVpS1.97
TBVpS1.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.44%
ROE -68.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.83%
FCFM N/A
ROA(3y)-15.07%
ROA(5y)-8.88%
ROE(3y)-28.44%
ROE(5y)-16.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.88%
GM growth 5Y-25.72%
F-Score1
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 875.43%
Cap/Sales 11.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.74
Quick Ratio 3.52
Altman-Z -0.8
F-Score1
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.94%
EPS Next Y166.67%
EPS Next 2Y106.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-76.93%
Revenue growth 3Y-45.36%
Revenue growth 5Y-28.23%
Sales Q2Q%-68.25%
Revenue Next Year20.83%
Revenue Next 2Y36.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year183.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y67.84%
OCF growth 3YN/A
OCF growth 5YN/A